These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19954345)

  • 21. A mouse model of melanoma driven by oncogenic KRAS.
    Milagre C; Dhomen N; Geyer FC; Hayward R; Lambros M; Reis-Filho JS; Marais R
    Cancer Res; 2010 Jul; 70(13):5549-57. PubMed ID: 20516123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generating and analyzing fish models of melanoma.
    Patton EE; Mathers ME; Schartl M
    Methods Cell Biol; 2011; 105():339-66. PubMed ID: 21951537
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Oppel F; Ki DH; Zimmerman MW; Ross KN; Tao T; Shi H; He S; Aster JC; Look AT
    Dis Model Mech; 2020 Aug; 13(8):. PubMed ID: 32651197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of human tissue to assess the oncogenic activity of melanoma-associated mutations.
    Chudnovsky Y; Adams AE; Robbins PB; Lin Q; Khavari PA
    Nat Genet; 2005 Jul; 37(7):745-9. PubMed ID: 15951821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated Hgf-Met Signaling Cooperates with Oncogenic BRAF to Drive Primary Cutaneous Melanomas and Angiotropic Lung Metastases in Mice.
    Braun AD; Mengoni M; Bonifatius S; Tüting T; Gaffal E
    J Invest Dermatol; 2020 Jul; 140(7):1410-1417.e2. PubMed ID: 31972251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma.
    Burd CE; Liu W; Huynh MV; Waqas MA; Gillahan JE; Clark KS; Fu K; Martin BL; Jeck WR; Souroullas GP; Darr DB; Zedek DC; Miley MJ; Baguley BC; Campbell SL; Sharpless NE
    Cancer Discov; 2014 Dec; 4(12):1418-29. PubMed ID: 25252692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas.
    Park SW; Davison JM; Rhee J; Hruban RH; Maitra A; Leach SD
    Gastroenterology; 2008 Jun; 134(7):2080-90. PubMed ID: 18549880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis.
    Yin C; Zhu B; Zhang T; Liu T; Chen S; Liu Y; Li X; Miao X; Li S; Mi X; Zhang J; Li L; Wei G; Xu ZX; Gao X; Huang C; Wei Z; Goding CR; Wang P; Deng X; Cui R
    Cell; 2019 Feb; 176(5):1113-1127.e16. PubMed ID: 30712867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation.
    Zingg D; Debbache J; Peña-Hernández R; Antunes AT; Schaefer SM; Cheng PF; Zimmerli D; Haeusel J; Calçada RR; Tuncer E; Zhang Y; Bossart R; Wong KK; Basler K; Dummer R; Santoro R; Levesque MP; Sommer L
    Cancer Cell; 2018 Jul; 34(1):69-84.e14. PubMed ID: 30008323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deciphering Melanoma Cell States and Plasticity with Zebrafish Models.
    Travnickova J; Patton EE
    J Invest Dermatol; 2021 Jun; 141(6):1389-1394. PubMed ID: 33340501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haplosufficiency of PAX3 for melanoma development in Tyr: NRASQ61K; Cdkn2a-/- mice allows identification and sorting of melanoma cells using a Pax3GFP reporter allele.
    Campagne C; Reyes-Gomez E; Loiodice S; Gadin S; Ezagal J; Bernex F; Abitbol M; Louise A; Beermann F; Panthier JJ; Aubin-Houzelstein G; Egidy G
    Melanoma Res; 2016 Feb; 26(1):12-20. PubMed ID: 26587692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential roles of the pRb and Arf/p53 pathways in murine naevus and melanoma genesis.
    Ferguson B; Konrad Muller H; Handoko HY; Khosrotehrani K; Beermann F; Hacker E; Soyer HP; Bosenberg M; Walker GJ
    Pigment Cell Melanoma Res; 2010 Dec; 23(6):771-80. PubMed ID: 20718941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
    Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression signatures of early-stage and advanced medaka melanomas.
    Klotz B; Kneitz S; Regensburger M; Hahn L; Dannemann M; Kelso J; Nickel B; Lu Y; Boswell W; Postlethwait J; Warren W; Kunz M; Walter RB; Schartl M
    Comp Biochem Physiol C Toxicol Pharmacol; 2018 Jun; 208():20-28. PubMed ID: 29162497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
    Reichrath J; Rass K
    Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event.
    Messenger ZJ; Hall JR; Jima DD; House JS; Tam HW; Tokarz DA; Smart RC
    Cell Death Dis; 2018 Oct; 9(11):1054. PubMed ID: 30323292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation.
    Kaufman CK; Mosimann C; Fan ZP; Yang S; Thomas AJ; Ablain J; Tan JL; Fogley RD; van Rooijen E; Hagedorn EJ; Ciarlo C; White RM; Matos DA; Puller AC; Santoriello C; Liao EC; Young RA; Zon LI
    Science; 2016 Jan; 351(6272):aad2197. PubMed ID: 26823433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cells.
    Eskandarpour M; Kiaii S; Zhu C; Castro J; Sakko AJ; Hansson J
    Int J Cancer; 2005 May; 115(1):65-73. PubMed ID: 15688405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations.
    Eskandarpour M; Hashemi J; Kanter L; Ringborg U; Platz A; Hansson J
    J Natl Cancer Inst; 2003 Jun; 95(11):790-8. PubMed ID: 12783933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
    Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
    Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.